The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Final multivariate analysis of obesity and survival in patients with node-positive primary breast cancer: The ADEBAR trial.
J. W. Janni
Consultant or Advisory Role - AstraZeneca; Sanofi
Honoraria - AstraZeneca; Sanofi
Research Funding - AstraZeneca; Sanofi
P. G. M. Hepp
No relevant relationships to disclose
U. Andergassen
No relevant relationships to disclose
N. Harbeck
No relevant relationships to disclose
B. K. Rack
No relevant relationships to disclose
J. K. Neugebauer
No relevant relationships to disclose
K. Annecke
No relevant relationships to disclose
A. Wischnik
No relevant relationships to disclose
W. Simon
No relevant relationships to disclose
M. Rezai
No relevant relationships to disclose
T. N. Fehm
No relevant relationships to disclose
A. Schneeweiss
No relevant relationships to disclose
P. A. Fasching
No relevant relationships to disclose
B. Gerber
No relevant relationships to disclose
T. Zwingers
No relevant relationships to disclose
H. L. Sommer
No relevant relationships to disclose
K. Friese
No relevant relationships to disclose
M. Kiechle
No relevant relationships to disclose